
Usk Therapeutics Private Limited
Specialty pharmaceutical and nutritional formulations manufacturing company based in Karnataka.
Specialty pharmaceutical and nutritional formulations manufacturing company based in Karnataka.
Usk Therapeutics Private Limited (UTPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 September 2021 (Three years and seven months 17 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakrishna Madakala, Puchalapalli Sankeerthi, Sadu Kameswari, and Two other members serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
U24290KA2021PTC152293
152293
Private Limited Indian Non-Government Company
27 Sep 2021
30 Sep 2024
31 Mar 2024
Unlisted
Roc Bangalore
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sadu Kameswari ![]() | Managing Director | 27-Sep-2021 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ramakrishna Madakala ![]() | Director | 27-Sep-2021 | Current |
Puchalapalli Sankeerthi ![]() | Director | 27-Sep-2021 | Current |
Sobha Velamuru ![]() | Director | 27-Sep-2021 | Current |
Katakam Ushasree ![]() | Director | 27-Sep-2021 | Current |
Usk Therapeutics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 211.69% increase in profit. The company's net worth Soared by an impressive increase of 274.49%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Usk Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ramakrishna Madakala is a mutual person
Katakam Ushasree is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Usk Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Usk Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usk Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Usk Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Usk Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Ramakrishna Reddy Madakala was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
Puchalapalli Sankeerthi was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
Sadu Kameswari was appointed as a Managing Director was appointed as a Managing Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
Sobha Velamuru was appointed as a Director was appointed as a Director on 27 Sep 2021 & has been associated with this company since 3 years 7 months .
Usk Therapeutics Private Limited was incorporated on 27 Sep 2021.
The authorized share capital of Usk Therapeutics Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 5 directors are associated with Usk Therapeutics Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Usk Therapeutics Private Limited is Flat No 102 1St Floor Sv Elegant Syno.2/1 2/7 Kumbena Agrahara, Belathur India, Kadugodi, Karnataka, 560067.
The corporate identification number (CIN) of Usk Therapeutics Private Limited is U24290KA2021PTC152293 and the company number is 152293 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2023 indicates that The net worth of Usk Therapeutics Private Limited has experienced an upsurge of 274.49%.
The most recent Balance Sheet for Usk Therapeutics Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.